Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
Algernon Pharmaceuticals (AGNPF) Stock Price & Analysis
71 Followers
AGNPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.04 - $0.21
Previous Close$0.08
Volume40.00
Average Volume (3M)13.19K
Market Cap
$1.68M
Enterprise Value$1.59M
Total Cash (Recent Filing)C$125.08K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)-0.3
Beta0.99
Next Earnings
Jul 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding20,015,762
10 Day Avg. Volume13,150
30 Day Avg. Volume13,185
Standard Deviation0.29
R-Squared0.00375
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.90
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Algernon Pharmaceuticals News
PremiumCompany Announcements
Algernon Pharmaceuticals Unveils Stroke Study Breakthrough
PremiumCompany Announcements
Algernon Pharmaceuticals Unveils Future Plans
PremiumCompany Announcements
Algernon Pharmaceuticals Advances DMT Stroke Study
Options Prices
Currently, No data available
---
Ownership Overview
50.89% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
49.11% Public Companies and
Individual Investors
AGNPF FAQ
What was Algernon Pharmaceuticals’s price range in the past 12 months?
Algernon Pharmaceuticals lowest stock price was $0.04 and its highest was $0.20 in the past 12 months.
What is Algernon Pharmaceuticals’s market cap?
Currently, no data Available
When is Algernon Pharmaceuticals’s upcoming earnings report date?
Algernon Pharmaceuticals’s upcoming earnings report date is Jul 26, 2024 which is in 84 days.
How were Algernon Pharmaceuticals’s earnings last quarter?
Algernon Pharmaceuticals released its earnings results on Apr 29, 2024. The company reported -$0.037 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.037.
Is Algernon Pharmaceuticals overvalued?
According to Wall Street analysts Algernon Pharmaceuticals’s price is currently Overvalued.
Does Algernon Pharmaceuticals pay dividends?
Algernon Pharmaceuticals does not currently pay dividends.
What is Algernon Pharmaceuticals’s EPS estimate?
Algernon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Algernon Pharmaceuticals have?
Algernon Pharmaceuticals has 20,015,762 shares outstanding.
What happened to Algernon Pharmaceuticals’s price movement after its last earnings report?
Algernon Pharmaceuticals reported an EPS of -$0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Algernon Pharmaceuticals?
Currently, no hedge funds are holding shares in AGNPF
---
Algernon Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.79%
12-Months-Change
Fundamentals
Return on Equity
-200.68%
Trailing 12-Months
Asset Growth
-40.80%
Trailing 12-Months
Company Description
Algernon Pharmaceuticals
Algernon Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the development of repurposed therapeutic drugs. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---